Task: Answer the multiple choice question.
Query: Which drug exhibits a 11.837\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) CCC(C)NC(=O)C1(O)c2cc(Br)ccc2NC(=O)N1c1cccc(OC)c1
b.) Cc1cc(C)nc(NC(=O)c2ccc(OC(C)C)cc2)n1
c.) O=C1OC2CC3CC1CC(O)(C3)C2
d.) Cc1ccc2nc(-c3ccncc3)[nH]c2c1
Answer: b. Cc1cc(C)nc(NC(=O)c2ccc(OC(C)C)cc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)nc(NC(=O)c2ccc(OC(C)C)cc2)n1
Cc1cc(C)nc(NC(=O)c2ccc(OC(C)C)cc2)n1
N-(4,6-dimethylpyrimidin-2-yl)-4-propan-2-yloxybenzamide